History and mission

TEDD ( Tissue Engineering for Drug Developemnt and Substance Testing) was established together with the introduction of 3D cell cultures technologies to the wider audience. The center aims at fostering 3D cell culture approaches for drug development, personalized, regenerative medicine and basic science, contributing actively to key technology development and translating in vitro assays into predictive tests of clinical and pharmaceutical relevance. In order to maximize the success, cooperation of partners with complementary skills – academia, industry (in particular biotechnology, pharmaceutical, medtech and cosmetics companies) and clinics is required. TEDD community strengthen the research and business location of Switzerland and Europe by responding to key medical, pharmaceutical and societal demands. By routine application of 3D tissue models, the 3Rs initiative will be implemented by reducing, refining and replacing animal experimentation.

 

More details…

Website Link…

 

Recent Posts

Women’s newly liberated expression redefines codes of beauty via Premium Beauty News

Kristel Adriaenssens Milet 1 April 2025 Social intelligence company Dynvibe, which specialises in behavioural marketing…

35th IFSCC Congress to take place in Cannes under the theme ‘Future is Science’ via SpecialChem

26 March 2025 The 35th IFSCC Congress will take place in Cannes from September 15…

CAIOME (Cosmetic AI + Microbiome) via Cosmoprof Awards

This AI-powered skin diagnostic device uses bio-optical technology alongside AI algorithms to analyze the skin’s…